SEC Filing Summary for Guyer Charles Greg

Charles Greg Guyer, EVP, Chief Technical Officer at BIOMARIN PHARMACEUTICAL INC, reported several transactions on March 13 and March 16, 2026. On March 13, 9109 shares of Common Stock were disposed of at a price of $58.51 per share, resulting in 70843 shares remaining. On March 16, 14990 shares of Common Stock were acquired at no cost, increasing the total shares to 85833. Additionally, on March 16, a stock option to buy 35680 shares of Common Stock was granted at a price of $57.43 per share, vesting over time starting March 16, 2027. Footnote F1 indicates these were restricted stock units, F2 notes a correction to direct holdings by one share, and F3 details the vesting schedule for the stock option.